HI SB326 | 2022 | Regular Session
Note: Carry Over of previous SB326
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 22 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 22 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Imposes dollar limits on specialty tiers in order to protect patients from unaffordable coinsurance or copayment amounts. Limits patients' coinsurance or copayment fees for specialty tier drugs to $150 per month for up to a thirty-day period supply. Allow patients to request an exception to obtain a specialty drug that would not otherwise be available on a health plan formulary.
Title
Relating To Health.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2021-12-10 | Carried over to 2022 Regular Session. | |
| 2021-01-25 | Senate | Referred to HTH, CPN. |
| 2021-01-22 | Senate | Passed First Reading. |
| 2021-01-22 | Senate | Introduced. |
Same As/Similar To
HB15 (Same As) 2021-12-10 - Carried over to 2022 Regular Session.
SB326 (Carry Over) 2021-01-25 - Referred to HTH, CPN.
SB326 (Carry Over) 2021-01-25 - Referred to HTH, CPN.
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=326&year=2022 |
| Text | https://www.capitol.hawaii.gov/session2022/bills/SB326_.HTM |
